Literature DB >> 7416739

Inhibition of dengue virus replication by amantadine hydrochloride.

W C Koff, J L Elm, S B Halstead.   

Abstract

The effect of amantadine hydrochloride (1-adamantanamine hydrochloride) on dengue virus replication was examined in vitro. Amantadine decreased the titers of all four types of dengue viruses grown in LLC-MK2 cells by greater than 90% at concentrations of 50 micrograms/ml. There was no evidence for any cytopathic effect of the drug at concentrations less than 100 micrograms/ml. Studies of the time of addition showed that the antiviral effect was maximal when drug was added to virus cultures immediately after the viral adsorption period. In addition, amantadine caused a marked reduction in the growth of dengue virus type 2 in both human and rhesus peripheral blood leukocytes without affecting cell viabili ty. These findings demonstrate that amantadine significantly inhibits the replication of dengue viruses in vitro and indicate a need to determine the efficacy of this drug against dengue virus infections in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7416739      PMCID: PMC283951          DOI: 10.1128/AAC.18.1.125

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Immunological enhancement of dengue virus replication.

Authors:  S B Halstead; J S Chow; N J Marchette
Journal:  Nat New Biol       Date:  1973-05-02

2.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

3.  Inhibition of in vitro proliferative responses of human lymphocytes by rimantadine hydrochloride.

Authors:  W C Koff; D L Peavy; V Knight
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

4.  Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections.

Authors:  N J Marchette; S B Halstead; W A Falkler; A Stenhouse; D Nash
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

5.  Replication of dengue viruses in cultures of peripheral blood leukocytes from dengue-immune rhesus monkeys.

Authors:  N J Marchette; S B Halstead; J S Chow
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

6.  Effect of amantadine hydrochloride on the response of human lymphocytes to phytohemagglutinin.

Authors:  W E Rawls; J L Melnick; G B Olson; P B Dent; R A Good
Journal:  Science       Date:  1967-10-27       Impact factor: 47.728

7.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

8.  Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host.

Authors:  S B Halstead; P Simasthien
Journal:  Yale J Biol Med       Date:  1970-04

9.  Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.

Authors:  S B Halstead
Journal:  Yale J Biol Med       Date:  1970-04

10.  Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses.

Authors:  S B Halstead; S Udomsakdi; P Simasthien; P Singharaj; P Sukhavachana; A Nisalak
Journal:  Yale J Biol Med       Date:  1970-04
View more
  11 in total

1.  Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys.

Authors:  C Ajariyakhajorn; M P Mammen; T P Endy; M Gettayacamin; A Nisalak; S Nimmannitya; D H Libraty
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

2.  Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin.

Authors:  W C Koff; R D Pratt; J L Elm; C N Venkateshan; S B Halstead
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

3.  Triple antiviral therapy in HCV positive patients who failed prior combination therapy.

Authors:  Silvia Fargion; Mauro Borzio; Alessandra Maraschi; Antonietta Cargnel
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

4.  Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.

Authors:  Reina Sasaki-Tanaka; Toshikatsu Shibata; Mitsuhiko Moriyama; Hiroaki Okamoto; Hirofumi Kogure; Tatsuo Kanda
Journal:  J Virol       Date:  2022-08-30       Impact factor: 6.549

5.  Tromantadine: inhibitor of early and late events in herpes simplex virus replication.

Authors:  K S Rosenthal; M S Sokol; R L Ingram; R Subramanian; R C Fort
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

6.  Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial.

Authors:  L E Adinolfi; R Utili; A Tonziello; G Ruggiero
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

7.  Treatment Effectiveness of Amantadine Against Dengue Virus Infection.

Authors:  Chieh-Cheng Lin; Wen-Ching Chen
Journal:  Am J Case Rep       Date:  2016-12-05

8.  Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C.

Authors:  G Teuber; T Berg; U Naumann; J Raedle; S Brinkmann; U Hopf; S Zeuzem
Journal:  J Viral Hepat       Date:  2001-07       Impact factor: 3.728

9.  Loperamide Inhibits Replication of Severe Fever with Thrombocytopenia Syndrome Virus.

Authors:  Shuzo Urata; Jiro Yasuda; Masaharu Iwasaki
Journal:  Viruses       Date:  2021-05-10       Impact factor: 5.048

10.  Microwave Optimized Synthesis of N-(adamantan-1-yl)-4-[(adamantan-1-yl)-sulfamoyl]benzamide and Its Derivatives for Anti-Dengue Virus Activity.

Authors:  Jacques Joubert; Eugene B Foxen; Sarel F Malan
Journal:  Molecules       Date:  2018-07-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.